Dinamika pendapatan YoY sajrone rolas wulan kepungkur: Arcellx Therapeutics (ACLX)

Logo grafis Arcellx (ACLX)

Arcellx is implementing advanced ddCAR technologies to combat oncohematology by investing in high-tech scientific potential. The business's success is based on clinical trial results and the scaling of cell product manufacturing. High demand for CAR-T therapy defines the market's development vector. Annual sales growth on a TTM basis demonstrates demand dynamics, where the indicator value reaches -80.10.

ACLX Wutah dodolan YoY (TTM) Arcellx (11.02.2024 - 09.05.2026)

Ringkesan rincian data analitis Arcellx, Inc. (ACLX)

- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
Pambiji fundamental perusahaan:Arcellx Corp - ACLX
Produk sing diprodhuksi arcellx.com

To assess the credit quality of Arcellx (ACLX), the analyst examines revenue expansion rates. Business resilience is supported by the use of the ddCAR platform and backing from a big pharma behemoth to capture the cancer therapy market. The trailing 12-month sales growth relative to the previous year measures the percentage increase in revenue over four quarters, revealing stagnant demand. This indicator serves as a filter to protect capital from overheated assets.